VSEE HEALTH, INC.
VSEENasdaq
$0.10
↓ -3.5%Jul 17 close · end-of-day
Price
1Y↓ -92.5%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$4.6M
Enterprise Value
$4.6M
P/E
—
P/S
0.3
P/B
0.7
EV/EBITDA
—
PEG
—
FCF Yield
-118.4%
Dividend Yield
—
Revenue (TTM)
$14.5M
Net Income (TTM)
-$13.4M
Free Cash Flow (TTM)
-$5.5M
Gross Margin
46.3%
Operating Margin
-74.2%
Net Margin
-92.4%
ROE
-211.3%
ROIC
-134.9%
Debt / Equity
0.2
Net Cash
$40,458.00
Return 1Y
-93.1%
Company profile
Telemedicine shouldn't be another EMR nightmare, and doctors don't need more apps they won't use. That's why we've made it easy for anyone to create a unified telehealth experience that's as simple and accessible as shopping online. Telehealth improves care outcomes, lowers costs, increases access, and alleviates clinician shortages. We are committed to innovating technology that allows our partners to harness the possibilities of telehealth and to progress our mission of making telehealth an everyday experience.
- CEO
- Milton Chen
- Sector
- Services
- Industry
- Healthcare
- Headquarters
- Florida
- Website
- vsee.com
Management & directors
- Chen MiltonCo-Chief Executive Officer
- Aisiku ImoigeleCo-Chief Executive Officer
- Leonard JerryChief Financial Officer
Roles derived from SEC Form 4 filings.
Earnings
VSEE Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$3.2M↓ -4.9%
Diluted EPS-$0.05↓ -79.2%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2022 | FY2023 | FY2024 | FY2024 | FY2025 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $5.8M | — | $10.4M | — | $14.6M |
| Gross profit | — | $3.8M | — | $7.2M | — | $7.4M |
| Operating income | -$3.6M | -$1.9M | — | -$62.2M | — | -$9.6M |
| Net income | -$3.2M | -$3.8M | — | -$57.7M | — | -$14.7M |
| Diluted EPS | -$0.25 | -$0.38 | — | -$5.65 | — | -$0.73 |
| Operating cash flow | -$1.4M | -$632,595.00 | — | -$5.8M | — | -$3.4M |
| Free cash flow | — | -$636,930.00 | — | -$5.8M | — | -$3.5M |
| Gross margin | — | 66.5% | — | 68.9% | — | 50.3% |
| Operating margin | — | -32.5% | — | -596.4% | — | -65.6% |
| Net margin | — | -65.3% | — | -553.7% | — | -100.6% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.7M | $3.4M | $3.7M | $3.3M | $3.4M | $4.0M | $3.9M | $3.2M |
| Gross profit | $776,996.00 | $2.8M | $2.4M | $1.9M | $1.6M | $2.1M | $1.8M | $1.2M |
| Operating income | -$932,523.00 | -$58.3M | -$3.0M | -$1.8M | -$2.3M | -$2.1M | -$3.4M | -$3.0M |
| Net income | -$634,122.00 | -$53.9M | -$3.2M | -$4.0M | -$2.6M | -$289,745.00 | -$7.9M | -$2.6M |
| Diluted EPS | -$0.12 | -$3.58 | -$1.96 | -$0.24 | -$0.16 | -$0.02 | -$0.31 | -$0.05 |
| Operating cash flow | -$3.2M | -$221,034.00 | -$3.0M | -$440,493.00 | -$324,601.00 | -$754,538.00 | -$1.9M | -$2.5M |
| Free cash flow | -$3.2M | -$226,028.00 | -$3.0M | -$452,366.00 | -$328,194.00 | -$761,848.00 | -$1.9M | -$2.5M |
| Gross margin | 45.4% | 83.0% | 63.8% | 56.0% | 46.9% | 52.1% | 46.7% | 37.9% |
| Operating margin | -54.5% | -1737.8% | -81.1% | -55.1% | -66.5% | -51.7% | -87.6% | -94.1% |
| Net margin | -37.0% | -1607.5% | -85.9% | -119.2% | -77.1% | -7.3% | -200.0% | -82.3% |
Company news
Jul 14, 2026
Jun 25, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-31 | CHEN MILTON· Co-Chief Executive Officer | J | 2,870,069 | $0.00 | $0.00 | filing |
| 2026-03-23 | Aisiku Imoigele· Co-Chief Executive Officer | Award | 78,689 | $0.61 | $48,000.29 | filing |
| 2026-03-23 | Aisiku Imoigele· Co-Chief Executive Officer | Award | 40,000 | $1.20 | $48,000.00 | filing |
| 2026-03-23 | Aisiku Imoigele· Co-Chief Executive Officer | Award | 41,379 | $1.16 | $47,999.64 | filing |
| 2026-03-23 | Aisiku Imoigele· Co-Chief Executive Officer | Award | 128,342 | $0.37 | $47,486.54 | filing |
| 2026-03-23 | Leonard Jerry· Chief Financial Officer | Award | 21,552 | $1.16 | $25,000.32 | filing |
| 2026-03-23 | Leonard Jerry· Chief Financial Officer | Award | 40,984 | $0.61 | $25,000.24 | filing |
| 2026-03-23 | Leonard Jerry· Chief Financial Officer | Award | 20,833 | $1.20 | $24,999.60 | filing |
| 2026-03-23 | Leonard Jerry· Chief Financial Officer | Award | 66,845 | $0.37 | $24,732.65 | filing |
| 2026-03-04 | O'SULLIVAN COLIN P. | Award | 40,107 | $0.37 | $15,000.02 | filing |
| 2026-03-04 | METZGER SCOTT | Award | 40,107 | $0.37 | $15,000.02 | filing |
| 2026-03-04 | LOWDERMILK KEVIN | Award | 40,107 | $0.37 | $15,000.02 | filing |
| 2026-03-04 | WICKERSHAM DAVID L. | Award | 40,107 | $0.37 | $15,000.02 | filing |
| 2026-03-04 | FAIRFAX CYDONII V. | Award | 40,107 | $0.37 | $15,000.02 | filing |
| 2026-02-23 | WICKERSHAM DAVID L. | C | 759,916 | $0.32 | $243,173.12 | filing |
| 2026-02-23 | WICKERSHAM DAVID L. | C | 105,251 | $0.65 | $68,413.15 | filing |
| 2025-11-06 | DIGITAL HEALTH SPONSOR LLC | J | 557,000 | — | — | filing |
| 2025-11-06 | DIGITAL HEALTH SPONSOR LLC | J | 557,000 | — | — | filing |
| 2025-09-19 | Leonard Jerry· Chief Financial Officer | Award | 135,724 | $2.18 | $295,878.32 | filing |
| 2025-09-19 | O'SULLIVAN COLIN P. | Award | 21,870 | $0.69 | $15,090.30 | filing |
| 2025-09-19 | METZGER SCOTT | Award | 21,870 | $0.69 | $15,090.30 | filing |
| 2025-09-19 | WICKERSHAM DAVID L. | Award | 21,870 | $0.69 | $15,090.30 | filing |
| 2025-09-19 | FAIRFAX CYDONII V. | Award | 21,870 | $0.69 | $15,090.30 | filing |
| 2025-09-19 | LOWDERMILK KEVIN | Award | 21,870 | $0.69 | $15,090.30 | filing |
| 2025-09-19 | LOWDERMILK KEVIN | Award | 12,500 | $1.20 | $15,000.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.